Clinical trials
Enrolling by invitation trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
200 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 6 |
| 2019 | 9 |
| 2020 | 3 |
| 2021 | 13 |
| 2022 | 18 |
| 2023 | 27 |
| 2024 | 37 |
| 2025 | 54 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 200 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Wellcome Sanger Institute | 7 |
| King's College London | 6 |
| Novo Nordisk A/S | 6 |
| University of Oxford | 5 |
| University of Ulster | 5 |
| Aston University | 4 |
| Imperial College London | 4 |
| Quadram Institute Bioscience | 4 |
| Sanofi | 4 |
| BioMarin Pharmaceutical | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 8 |
| Genetic Diseases, Inborn | 7 |
| Cardiovascular Diseases | 6 |
| Angioedemas, Hereditary | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Obesity | 5 |
| Bone Diseases | 4 |
| Epilepsy | 4 |
| Muscular Dystrophy, Duchenne | 4 |
| Musculoskeletal Diseases | 4 |
Trials
Showing 51 to 75 of 200. Each trial links to its page on Pharma Observatory.
100 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.